Vizientinc.com does not support this browser (Internet Explorer)
This will impact your experience of the Vizient website and may prevent you from accessing certain features and important security updates.
To improve your browsing experience we recommend you upgrade your browser to Safari, Chrome, Microsoft Edge or Firefox
2022 summaries
December 22 - Vizient regulatory summary of the CMS Proposed Rule on CY 2024 Policy and Technical Changes to the Medicare Advantage and Part D
Vizient, Inc.
December 19 - Vizient regulatory summary of the CMS Proposed Rule on Advancing Interoperability and Improving Prior Authorization ProcessesVizient, Inc.
September 28 - Vizient regulatory summary of the HHS proposed rule, “Nondiscrimination in Health Programs and Activities”Vizient, Inc.
August 30 - Vizient regulatory summary of Requirements Related to Surprise Billing: Final RulesVizient, Inc.
August 16 - Vizient Legislative Summary of Health Care Provisions in The Inflation Reduction ActVizient, Inc.
August 5 - Vizient regulatory summary of the CY 2023 Outpatient Prospective Payment System proposed ruleVizient, Inc.
July 28 - Vizient regulatory summary of the CY 2023 Physician Fee Schedule (PFS) proposed ruleVizient, Inc.
July 12 - Vizient regulatory summary of Medicare and Medicaid Conditions of Participation (CoPs) for Rural Emergency Hospitals (REHs) and Critical Access Hospital (CAH) CoP UpdatesVizient, Inc.
May 6 - Vizient regulatory summary of the FY 2023 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Prospective Payment System proposed ruleVizient, Inc.
2021 summaries
November 11 - Vizient regulatory summary of the "Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination" interim final rule
Vizient, Inc.
October 19 - Vizient regulatory summary of Requirements Related to Surprise Billing: Part 3Vizient, Inc.
September 24 - Vizient regulatory summary of Requirements Related to Surprise Billing: Part 2Vizient, Inc.
Aug. 9 - Vizient regulatory summary of the CY 2022 Outpatient Prospective Payment System proposed rule.VIzient, Inc.
July 30 - Vizient regulatory summary of the CY 2022 Physician Fee Schedule proposed ruleVizient, Inc.
July 15 - Vizient regulatory summary of Requirements Related to Surprise Billing: Part 1"Vizient, Inc.
May 10 - Vizient regulatory summary of the FY 2022 Inpatient Prospective Payment System proposed ruleVizient, Inc.
March 31 - Future Directions of the Unapproved Drugs ProgramVizient, Inc.
2020 summaries
December 3 - Vizient Summary of The Most Favored Nation Model
Vizient, Inc.
November 17 - Vizient Summary of the CMS Interim Final Rule on Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health EmergencyVizient, Inc.
November 10 - Vizient Post-Election Analysis 2020, The Impact on Health Care & HospitalsVizient, Inc.
October 13 - Vizient Summary of 2020 Presidential Health Care PlatformsVizient, Inc.
September 11 –Vizient regulatory summary of the FY 2021 Inpatient Prospective Payment System final ruleVizient, Inc.
September 2 – Vizient Summary of the CMS Interim Final Rule on Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health EmergencyVizient, Inc.
August 24 - Vizient regulatory summary of the CY 2021 Physician Fee Schedule and Quality Payment Program proposed ruleVizient, Inc.
August 14 - Vizient regulatory summary of the CY 2021 Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System and Quality Reporting Programs proposed ruleVizient, Inc.
May 28 - Vizient regulatory summary of the FY 2021 Inpatient Prospective Payment System proposed ruleVizient, Inc.
May 18 – COVID-19 Funding Opportunities Potentially Applicable to Health Care FacilitiesVizient, Inc.
April 7 – Vizient Summary of the CMS Interim Final Rule on Policy and Regulatory Revisions in Response to the COVID-19 Public Health EmergencyVizient, Inc.
March 31 - Vizient Summary of the Coronavirus Aid, Relief, and Economic Security (CARES) ActVizient, Inc.
March 24 - Vizient summary of the Families First Coronavirus Response ActVizient, Inc.
January 27 – Vizient Regulatory Summary of the Importation of Prescription Drugs Proposed RuleVizient, Inc.